[Hepatitis C and liver transplantation].
Durand
François
F
Service d'Hépatologie et INSERM U481, Hôpital Beaujon, 100, boulevard du Général-Leclerc, 92110 Clichy.
D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000601:surgery; D004796:Clinical Enzyme Tests; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery* / Q000821:virology; D006801:Humans; D007165:Immunosuppression Therapy; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery; D008113:Liver Neoplasms / Q000209:etiology / Q000601:surgery; D016031:Liver Transplantation; D010865:Pilot Projects; D012367:RNA, Viral / Q000097:blood; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors; D014019:Tissue Donors; D000637:Transaminases / Q000097:blood
D000998:Antiviral Agents; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons; D000637:Transaminases